title: [Clinical manifestations of Menkes disease vary according to patient's genotype and the initiation time of treatment with copper-histidine injections].
authors.forename: Mariko
authors.initials: M
authors.lastname: Yagi
authors.forename: Noriko
authors.initials: N
authors.lastname: Kusunoki
authors.forename: Tomoko
authors.initials: T
authors.lastname: Lee
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Awano
authors.forename: Hiroko
authors.initials: H
authors.lastname: Kodama
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Takeshima
authors.forename: Kazumoto
authors.initials: K
authors.lastname: Iijima
mesh_terms: D000251:Adenosine Triphosphatases / Q000235:genetics*; D001921:Brain / Q000473:pathology; D027682:Cation Transport Proteins / Q000235:genetics*; D003300:Copper / Q000008:administration & dosage*; D000073840:Copper-Transporting ATPases; D016368:Frameshift Mutation; D005838:Genotype; D006639:Histidine / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008279:Magnetic Resonance Imaging; D008297:Male; D007706:Menkes Kinky Hair Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D020125:Mutation, Missense; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D027682:Cation Transport Proteins; D006639:Histidine; D003300:Copper; D000251:Adenosine Triphosphatases; C081184:ATP7A protein, human; D000073840:Copper-Transporting ATPases